Copyright
©The Author(s) 2020.
World J Stem Cells. Nov 26, 2020; 12(11): 1377-1395
Published online Nov 26, 2020. doi: 10.4252/wjsc.v12.i11.1377
Published online Nov 26, 2020. doi: 10.4252/wjsc.v12.i11.1377
MSCs markers after 1 d co-cultivation with non-activated and activated lymphocytes (PHA) | Wilks'Lambda | Partial | F-remove | P-level | Coefficients of discriminant function | |
No GVHD1 | GVHD2 | |||||
HLA-DR | 0.572005 | 0.625895 | 11.95423 | 0.002488 | -0.00358 | 0.0213 |
CD146 | 0.439602 | 0.814407 | 4.55774 | 0.045330 | -0.01545 | 0.0095 |
CD73 PHA | 0.517153 | 0.692280 | 8.89005 | 0.007375 | 4.30313 | -0.6335 |
CD105 | 0.499794 | 0.716325 | 7.92028 | 0.010713 | 9.05802 | -1.9000 |
CD105 PHA | 0.419957 | 0.852503 | 3.46032 | 0.077629 | 2.65834 | 11.3187 |
CD54 | 0.404184 | 0.885773 | 2.57915 | 0.123954 | -0.01228 | 0.0118 |
- Citation: Petinati N, Kapranov N, Davydova Y, Bigildeev A, Pshenichnikova O, Karpenko D, Drize N, Kuzmina L, Parovichnikova E, Savchenko V. Immunophenotypic characteristics of multipotent mesenchymal stromal cells that affect the efficacy of their use in the prevention of acute graft vs host disease. World J Stem Cells 2020; 12(11): 1377-1395
- URL: https://www.wjgnet.com/1948-0210/full/v12/i11/1377.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i11.1377